Skip to main content
Top
Published in: Digestive Diseases and Sciences 11/2012

01-11-2012 | Original Article

Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice

Authors: Atsunori Tsuchiya, Michitaka Imai, Hiroteru Kamimura, Masaaki Takamura, Satoshi Yamagiwa, Tatsuki Sugiyama, Minoru Nomoto, Toshio Heike, Takashi Nagasawa, Tatsutoshi Nakahata, Yutaka Aoyagi

Published in: Digestive Diseases and Sciences | Issue 11/2012

Login to get access

Abstract

Background

The chemokine SDF-1 and its receptor CXCR4 are essential for the proper functioning of multiple organs. In the liver, cholangiocytes and hepatic progenitor cells (HPCs) are the main cells that produce SDF-1, and SDF-1 is thought to be essential for HPC-stimulated liver regeneration.

Aims

In this study, CXCR4 conditionally targeted mice were used to analyze the role of SDF-1 in chronically damaged liver.

Methods

Chronic liver damage was induced in MxCre CXCR4f/null mice and the control MxCre CXCR4f/wt mice by CCl4. Serum markers were analyzed to assess liver function and damage, the number of cytokeratin-positive cells as a measure of HPCs, and the extent of liver fibrosis. Additional parameters relating to liver damage, such as markers of HPCs, liver function, MMPs, and TIMPs were measured by real-time PCR.

Results

Serum ALT was significantly higher in MxCre CXCR4f/null mice than MxCre CXCR4f/wt mice. The number of cytokeratin-positive cells and the area of fibrosis were also increased in the MxCre CXCR4f/null mice. The expression of mRNAs for several markers related to hepatic damage and regeneration was also increased in the liver of MxCre CXCR4f/null mice, including primitive HPC marker prominin-1, MMP9, TNF-α, and α-SMA.

Conclusions

MxCre CXCR4f/null mice were susceptible to severe chronic liver damage, suggesting that SDF-1-CXCR4 signals are important for liver regeneration and preventing the progression of liver disease. Modulation of SDF-1 may therefore be a promising treatment strategy for patients with chronic liver disease.
Literature
2.
go back to reference Tsuchiya A, Kamimura H, Takamura M, et al. Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas. Hepatol Res. 2009;39:1080–1090.PubMedCrossRef Tsuchiya A, Kamimura H, Takamura M, et al. Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas. Hepatol Res. 2009;39:1080–1090.PubMedCrossRef
3.
go back to reference Tsuchiya A, Heike T, Fujino H, et al. Long-term extensive expansion of mouse hepatic stem/progenitor cells in a novel serum-free culture system. Gastroenterology. 2005;128:2089–2104.PubMedCrossRef Tsuchiya A, Heike T, Fujino H, et al. Long-term extensive expansion of mouse hepatic stem/progenitor cells in a novel serum-free culture system. Gastroenterology. 2005;128:2089–2104.PubMedCrossRef
4.
go back to reference Tsuchiya A, Heike T, Baba S, et al. Long-term culture of postnatal mouse hepatic stem/progenitor cells and their relative developmental hierarchy. Stem Cells. 2007;25:895–902.PubMedCrossRef Tsuchiya A, Heike T, Baba S, et al. Long-term culture of postnatal mouse hepatic stem/progenitor cells and their relative developmental hierarchy. Stem Cells. 2007;25:895–902.PubMedCrossRef
5.
go back to reference Miyajima A, Kinoshita T, Tanaka M, et al. Role of oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev. 2000;11:177–183.PubMedCrossRef Miyajima A, Kinoshita T, Tanaka M, et al. Role of oncostatin M in hematopoiesis and liver development. Cytokine Growth Factor Rev. 2000;11:177–183.PubMedCrossRef
6.
go back to reference Nagasawa T, Kaisho T, Kishimoto T, et al. Generation and characterization of a monoclonal antibody that inhibits stromal cell-dependent B lymphopoiesis. J Immunol. 1994;152:2788–2797.PubMed Nagasawa T, Kaisho T, Kishimoto T, et al. Generation and characterization of a monoclonal antibody that inhibits stromal cell-dependent B lymphopoiesis. J Immunol. 1994;152:2788–2797.PubMed
7.
go back to reference Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA. 1994;91:2305–2309.PubMedCrossRef Nagasawa T, Kikutani H, Kishimoto T. Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA. 1994;91:2305–2309.PubMedCrossRef
8.
go back to reference Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635–638.PubMedCrossRef Nagasawa T, Hirota S, Tachibana K, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature. 1996;382:635–638.PubMedCrossRef
9.
go back to reference Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998;393:591–594.PubMedCrossRef Tachibana K, Hirota S, Iizasa H, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature. 1998;393:591–594.PubMedCrossRef
10.
go back to reference Tokoyoda K, Egawa T, Sugiyama T, et al. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20:707–718.PubMedCrossRef Tokoyoda K, Egawa T, Sugiyama T, et al. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity. 2004;20:707–718.PubMedCrossRef
11.
go back to reference Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977–988.PubMedCrossRef Sugiyama T, Kohara H, Noda M, et al. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity. 2006;25:977–988.PubMedCrossRef
12.
go back to reference Cheng Z, Liu X, Ou L, et al. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther. 2008;22:363–371.PubMedCrossRef Cheng Z, Liu X, Ou L, et al. Mobilization of mesenchymal stem cells by granulocyte colony-stimulating factor in rats with acute myocardial infarction. Cardiovasc Drugs Ther. 2008;22:363–371.PubMedCrossRef
13.
go back to reference Sanematsu F, Hirashima M, Laurin M, et al. DOCK180 is a Rac activator that regulates cardiovascular development by acting downstream of CXCR4. Circ Res. 2010;107:1102–1105.PubMedCrossRef Sanematsu F, Hirashima M, Laurin M, et al. DOCK180 is a Rac activator that regulates cardiovascular development by acting downstream of CXCR4. Circ Res. 2010;107:1102–1105.PubMedCrossRef
14.
go back to reference Ara T, Tokoyoda K, Okamoto R, et al. The role of CXCL12 in the organ-specific process of artery formation. Blood. 2005;105:3155–3161.PubMedCrossRef Ara T, Tokoyoda K, Okamoto R, et al. The role of CXCL12 in the organ-specific process of artery formation. Blood. 2005;105:3155–3161.PubMedCrossRef
15.
go back to reference Hick AC, van Eyll JM, Cordi S, et al. Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. BMC Dev Biol. 2009;9:66.PubMedCentralPubMedCrossRef Hick AC, van Eyll JM, Cordi S, et al. Mechanism of primitive duct formation in the pancreas and submandibular glands: a role for SDF-1. BMC Dev Biol. 2009;9:66.PubMedCentralPubMedCrossRef
16.
go back to reference Stumm RK, Zhou C, Ara T, et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci. 2003;23:5123–5130.PubMed Stumm RK, Zhou C, Ara T, et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci. 2003;23:5123–5130.PubMed
17.
go back to reference Zhu Y, Yu T, Zhang XC, et al. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci. 2002;5:719–720.PubMedCentralPubMedCrossRef Zhu Y, Yu T, Zhang XC, et al. Role of the chemokine SDF-1 as the meningeal attractant for embryonic cerebellar neurons. Nat Neurosci. 2002;5:719–720.PubMedCentralPubMedCrossRef
18.
go back to reference Zhu Y, Matsumoto T, Mikami S, et al. SDF1/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation. Development. 2009;136:1919–1928.PubMedCrossRef Zhu Y, Matsumoto T, Mikami S, et al. SDF1/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation. Development. 2009;136:1919–1928.PubMedCrossRef
19.
go back to reference Mavier P, Martin N, Couchie D, et al. Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am J Pathol. 2004;165:1969–1977.PubMedCrossRef Mavier P, Martin N, Couchie D, et al. Expression of stromal cell-derived factor-1 and of its receptor CXCR4 in liver regeneration from oval cells in rat. Am J Pathol. 2004;165:1969–1977.PubMedCrossRef
20.
go back to reference Zheng D, Oh SH, Jung Y, et al. Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1. Am J Pathol. 2006;169:2066–2074.PubMedCrossRef Zheng D, Oh SH, Jung Y, et al. Oval cell response in 2-acetylaminofluorene/partial hepatectomy rat is attenuated by short interfering RNA targeted to stromal cell-derived factor-1. Am J Pathol. 2006;169:2066–2074.PubMedCrossRef
21.
go back to reference Hong F, Tuyama A, Lee TF, et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009;49:2055–2067.PubMedCentralPubMedCrossRef Hong F, Tuyama A, Lee TF, et al. Hepatic stellate cells express functional CXCR4: role in stromal cell-derived factor-1alpha-mediated stellate cell activation. Hepatology. 2009;49:2055–2067.PubMedCentralPubMedCrossRef
22.
go back to reference Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124:175–189.PubMedCrossRef Grunewald M, Avraham I, Dor Y, et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell. 2006;124:175–189.PubMedCrossRef
23.
go back to reference Kuhn R, Schwenk F, Aguet M, et al. Inducible gene targeting in mice. Science. 1995;269:1427–1429.PubMedCrossRef Kuhn R, Schwenk F, Aguet M, et al. Inducible gene targeting in mice. Science. 1995;269:1427–1429.PubMedCrossRef
24.
go back to reference Rountree CB, Barsky L, Ge S, et al. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells. 2007;25:2419–2429.PubMedCrossRef Rountree CB, Barsky L, Ge S, et al. A CD133-expressing murine liver oval cell population with bilineage potential. Stem Cells. 2007;25:2419–2429.PubMedCrossRef
25.
go back to reference Kojima Y, Acar A, Eaton EN, et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblast. Proc Natl Acad Sci USA. 2010;107:20009–20014.PubMedCrossRef Kojima Y, Acar A, Eaton EN, et al. Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblast. Proc Natl Acad Sci USA. 2010;107:20009–20014.PubMedCrossRef
26.
go back to reference Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35:233–245.PubMedCrossRef Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol. 2004;35:233–245.PubMedCrossRef
27.
go back to reference Balaban YH, Korkusuz P, Simsek H, et al. Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol. 2007;6:242–250.PubMed Balaban YH, Korkusuz P, Simsek H, et al. Dipeptidyl peptidase IV (DDP IV) in NASH patients. Ann Hepatol. 2007;6:242–250.PubMed
Metadata
Title
Increased Susceptibility to Severe Chronic Liver Damage in CXCR4 Conditional Knock-Out Mice
Authors
Atsunori Tsuchiya
Michitaka Imai
Hiroteru Kamimura
Masaaki Takamura
Satoshi Yamagiwa
Tatsuki Sugiyama
Minoru Nomoto
Toshio Heike
Takashi Nagasawa
Tatsutoshi Nakahata
Yutaka Aoyagi
Publication date
01-11-2012
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 11/2012
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-012-2239-8

Other articles of this Issue 11/2012

Digestive Diseases and Sciences 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine